In addition, the downregulation of CDR1as has been observed in glioma wherein it has been shown to bind the DNA-binding domain of the p53 tumor suppressor protein, thus inhibiting the ubiquitination and degradation of p53. The gene discussed is TP53; the disease is central nervous system cancer.